• Enzon said a 1-for-100 reverse stock split will take effect at 4:30 pm ET.
• Trading is expected to begin on a split-adjusted basis at the next market open.
• At the effective time, each 100 issued and outstanding common shares will be combined into 1 share.
• No fractional shares will be issued, and fractional entitlements will be settled in cash.
• The reverse split was completed to make available authorized common shares for the anticipated merger with Viskase Companies and a related exchange offer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enzon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-033624), on March 24, 2026, and is solely responsible for the information contained therein.